Biological Therapy Analysis & Statistics, July 2014 (p2)

Talk to Louis

+1 718 618 4302

Search inside this page

All regions

You might be interested in: stem cell, cell therapy, tissue engineering, more »

31-60 of about 400 reports

Purchase Reports From Reputable Market Research Publishers

Chemokine (C-C Motif) Ligand 2 (CCL2 or Monocyte Chemotactic Protein-1) Inhibitors -Pipeline Insights, 2014

Chemokine (C-C Motif) Ligand 2 (CCL2 or Monocyte Chemotactic Protein-1) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Chemokine (C-C Motif) Ligand 2 (CCL2 or Monocyte Chemotactic Protein-1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across ...

  • Industries : Biological Therapy
Chemokine Receptor Antagonists -Pipeline Insights, 2014

Chemokine Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Chemokine Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Biological Therapy
Fibroblast Activation Protein (FAP or Seprase) Inhibitors -Pipeline Insights, 2014

Fibroblast Activation Protein (FAP or Seprase) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fibroblast Activation Protein (FAP or Seprase) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Biological Therapy
Fibroblast Growth Factor (FGF) Inhibitors -Pipeline Insights, 2014

Fibroblast Growth Factor (FGF) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fibroblast Growth Factor (FGF) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor (FGFR) Agonists -Pipeline Insights, 2014

Fibroblast Growth Factor Receptor (FGFR) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fibroblast Growth Factor Receptor (FGFR) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Biological Therapy
Fibroblast Growth Factor 1 (FGF-1) Inhibitors -Pipeline Insights, 2014

Fibroblast Growth Factor 1 (FGF-1) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fibroblast Growth Factor 1 (FGF-1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor (FGFR) Inhibitors -Pipeline Insights, 2014

Fibroblast Growth Factor Receptor (FGFR) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fibroblast Growth Factor Receptor (FGFR) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists -Pipeline Insights, 2014

Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 1 (FGFR1) Inhibitors -Pipeline Insights, 2014

Fibroblast Growth Factor Receptor 1 (FGFR1) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fibroblast Growth Factor Receptor 1 (FGFR1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors -Pipeline Insights, 2014

Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors -Pipeline Insights, 2014

Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors -Pipeline Insights, 2014

Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Biological Therapy
G-CSF Inhibitors -Pipeline Insights, 2014

G-CSF Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“G-CSF Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is ...

  • Industries : Biological Therapy
Granulocyte-Macrophage Colony-Stimulating Factor Receptor (GM-CSFR) Agonists -Pipeline Insights, 2014

Granulocyte-Macrophage Colony-Stimulating Factor Receptor (GM-CSFR) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Granulocyte-Macrophage Colony-Stimulating Factor Receptor (GM-CSFR) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this ...

  • Industries : Biological Therapy
Hedgehog Signaling Pathway Antagonists -Pipeline Insights, 2014

Hedgehog Signaling Pathway Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Hedgehog Signaling Pathway Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Biological Therapy
Hepatocyte growth factor (HGF) mimetic -Pipeline Insights, 2014

Hepatocyte growth factor (HGF) mimetic -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Hepatocyte growth factor (HGF) mimetic-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Biological Therapy
Integrase Inhibitors -Pipeline Insights, 2014

Integrase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Integrase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Biological Therapy
Lymphocyte Function-Associated Antigen 1 (LFA-1) Antagonist -Pipeline Insights, 2014

Lymphocyte Function-Associated Antigen 1 (LFA-1) Antagonist -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Lymphocyte Function-Associated Antigen 1 (LFA-1) Antagonist-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Biological Therapy
Matrix Metalloproteinase 12 (MMP-12 or Macrophage Metalloelastase) Inhibitors -Pipeline Insights, 2014

Matrix Metalloproteinase 12 (MMP-12 or Macrophage Metalloelastase) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Matrix Metalloproteinase 12 (MMP-12 or Macrophage Metalloelastase) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this ...

  • Industries : Biological Therapy
Notch Signaling Pathway Inhibitors -Pipeline Insights, 2014

Notch Signaling Pathway Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Notch Signaling Pathway Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Biological Therapy
T Cell Inhibitors -Pipeline Insights, 2014

T Cell Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“T Cell Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Biological Therapy
Wnt Signaling Pathway Inhibitors -Pipeline Insights, 2014

Wnt Signaling Pathway Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Wnt Signaling Pathway Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Biological Therapy
GM-CSF Inhibitors -Pipeline Insights, 2014

GM-CSF Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“GM-CSF Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Biological Therapy
Herceptin-Drug Insights,2014

Herceptin-Drug Insights,2014

  • $ 1 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's pharmaceuticals report, “Herceptin - Drug Insights, 2014” provides Herceptin marketed details and API Manufacturers details across the globe along with the location. In addition, it ...

  • Industries : Biological Therapy
  • Countries : United States
Procrit-Drug Insights,2014

Procrit-Drug Insights,2014

  • $ 1 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's pharmaceuticals report, “Procrit - Drug Insights, 2014” provides Procrit marketed details and API Manufacturers details across the globe along with the location. In addition, it covers ...

  • Industries : Biological Therapy
  • Countries : United States
Rituxan-Drug Insights,2014

Rituxan-Drug Insights,2014

  • $ 1 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's pharmaceuticals report, “Rituxan - Drug Insights, 2014” provides Rituxan marketed details and API Manufacturers details across the globe along with the location. In addition, it covers ...

  • Industries : Biological Therapy
  • Countries : United States
Neupogen-Drug Insights,2014

Neupogen-Drug Insights,2014

  • $ 1 000
  • Industry report
  • June 2014
  • by Delve Insight

DelveInsight's pharmaceuticals report, “Neupogen - Drug Insights, 2014” provides Neupogen marketed details and API Manufacturers details across the globe along with the location. In addition, it covers ...

  • Industries : Biological Therapy
  • Countries : United States
Cytograft Tissue Engineering, Inc. - Product Pipeline Analysis, 2014 Update

Cytograft Tissue Engineering, Inc. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • June 2014
  • by Global Data

Summary Cytograft Tissue Engineering, Inc. (CTE) is a genetic engineering company. The company develops cell-based therapies to repair and rebuild diseased tissues and organs. It has developed a regenerative ...

  • Industries : Biological Therapy
  • Countries : United States
Bioheart, Inc. (BHRT) - Product Pipeline Analysis, 2014 Update

Bioheart, Inc. (BHRT) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • May 2014
  • by Global Data

Summary Bioheart, Inc. (Bioheart) is a biotechnology company. It focuses solely on providing cell technologies that aid in the treatment of cardiovascular and related diseases. Its product candidates ...

  • Industries : Biological Therapy
  • Countries : United States
Physician Views: Are neurologists ready to embrace gene therapy?

Physician Views: Are neurologists ready to embrace gene therapy?

  • $ 645
  • Industry report
  • June 2014
  • by Firstword Pharma

Description As recently noted by Forbes, the biotech bull market of 2013 has helped to revive an approach to drug development that had become largely abandoned and pursued by only a few devoted believers. ...

  • Industries : Biological Therapy
  • Countries : United States
About 600 reports

Download Unlimited Documents from Trusted Public Sources

Avagenesis - Company Report, July 2014

  • Avagenesis Corp. (tsxv: Vva) - Unique Automated Bioprocessing an...
  • July 2014
    25 pages
  • Stem Cell  

    Cell Therapy  

  • United States  

    Taiwan  

View report >

35 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Bioheart Inc.

United States

StemCells Inc.

United States

Geron Corp.

United States

Osiris Therapeutics Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.